Idiopathic urticaria. Idiopathic urticaria
Conditions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Patients must be older than eighteen years. Patients must have a diagnosis of idiopathic urticaria and positive prick test results for airborne antigens. Patients must choose from adult allergy clinics and declare their informed consent to participate in the study.
Exclusion criteria
Exclusion criteria: Patients who are under treatment other than antihistamines by a doctor specializing in asthma and allergies. Patients who cannot participate during six months. Patients who had serious side effects due to corticosteroids before the start of the study. Patients who have serious side effects caused by the use of corticosteroids during the study period.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Primary outcome measures include the frequency and severity of urticaria symptoms, which are evaluated using valid scoring systems such as the Urticaria Activity Score and the Urticaria Severity Score. Timepoint: At the beginning of the study (before the start of the intervention) and six months after the start of corticosteroid use. Method of measurement: Urticaria severity and activity questionnaire. | — |
Secondary
| Measure | Time frame |
|---|---|
| Secondary outcome measures will include the impact of urticaria on quality of life and daily activities, which will be evaluated using age-appropriate validation questionnaires. Timepoint: At the beginning of the study (before the start of the intervention) and six months later. Method of measurement: Questionnaire of the effect of urticaria on the quality of life. | — |
Countries
Iran (Islamic Republic of)
Contacts
Shiraz University of Medical Sciences